N-Cyclopropyl-N-[(4-methoxyphenyl)methyl]-3-nitrobenzene-1-sulfonamide

Catalog No. :
ACECWX110
CAS No. :
1808470-41-8
Molecular Formula :
C17H18N2O5S
Molecular Weight :
362.41

IUPAC Name:N-cyclopropyl-N-(4-methoxybenzyl)-3-nitrobenzenesulfonamide

N-Cyclopropyl-N-[(4-methoxyphenyl)methyl]-3-nitrobenzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$661.00Login to see priceInquiryInquiry
5g95%$1803.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Cyclopropyl-N-[(4-methoxyphenyl)methyl]-3-nitrobenzene-1-sulfonamide
IUPAC NameN-cyclopropyl-N-(4-methoxybenzyl)-3-nitrobenzenesulfonamide
MDL No.MFCD29043757
Molecular FormulaC17H18N2O5S
Molecular Weight362.41
SMILESCOC1=CC=C(C=C1)CN(S(=O)(C2=CC([N+]([O-])=O)=CC=C2)=O)C3CC3
InChI KeyZLDJQSSSKXVVJR-UHFFFAOYSA-N
SynonymBenzenesulfonamide, N-cyclopropyl-N-[(4-methoxyphenyl)methyl]-3-nitro-;N-cyclopropyl-N-[(4-methoxyphenyl)methyl]-3-nitrobenzene-1-sulfonamide
CAS No.1808470-41-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACECWX110 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZLT583 route compound structure diagram
    ACBZLT58370894-71-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACECWX110 route product structure diagram
    ACECWX1101808470-41-8
Inquiry

2. ACECWX110 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACECWX110 route product structure diagram
    ACECWX1101808470-41-8
Inquiry

Comments (0)